Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion
Phase 3
Completed
- Conditions
- Chalazion
- Interventions
- Drug: Placebo TDSDrug: SUN-131 1.5% TDS
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Senju USA, Inc.
- Target Recruit Count
- 263
- Registration Number
- NCT03248440
- Locations
- 🇺🇸
SUN-131-03 Investigational Site, Racine, Wisconsin, United States
Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
Phase 2
Completed
- Conditions
- Chalazion
- Interventions
- Drug: SUN-131 1.5% TDSDrug: Placebo TDS
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- Senju USA, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT02338648
- Locations
- 🇺🇸
WCCT Global Ophthalmology Research, Santa Ana, California, United States
🇺🇸Corneal Consultants of Colorado, P.C., Littleton, Colorado, United States
🇺🇸George Washington University Medical Faculty Association, Washington, D.C., District of Columbia, United States
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Senju USA, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT00836485
- Locations
- 🇺🇸
Ora, Andover, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath